At Memorial Sloan Kettering Cancer Center (MSKCC), a CD19-28z CAR T-cell was evaluated in a phase 1 trial of 53 adults with R/R B-ALL. The gene discussed is CD19; the disease is acute lymphoblastic leukemia.